7-Nitro-2,3,4,5-tetrahydro-1,4-benzoxazepine

Catalog No. :
ACJISY353
CAS No. :
216008-29-6
Molecular Formula :
C9H10N2O3
Molecular Weight :
194.19

IUPAC Name:7-nitro-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine

7-Nitro-2,3,4,5-tetrahydro-1,4-benzoxazepine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$185.00Login to see priceInquiryInquiry
100mg95%$268.00Login to see priceInquiryInquiry
250mg95%$378.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Nitro-2,3,4,5-tetrahydro-1,4-benzoxazepine
IUPAC Name7-nitro-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine
MDL No.MFCD22371138
Molecular FormulaC9H10N2O3
Molecular Weight194.19
SMILESO=[N+](C1=CC=C(OCCNC2)C2=C1)[O-]
InChI KeyXLSJIONOSGAQDN-UHFFFAOYSA-N
Synonym2,3,4,5-Tetrahydro-7-nitro-1,4-benzoxapine;7-Nitro-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepine;1,4-Benzoxazepine, 2,3,4,5-tetrahydro-7-nitro-;7-Nitro-2,3,4,5-tetrahydro-1,4-benzoxazepine
CAS No.216008-29-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJISY353 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJISY353 route product structure diagram
    ACJISY353216008-29-6
Inquiry

2. ACJISY353 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACJISY353 route product structure diagram
    ACJISY353216008-29-6
Inquiry

Comments (0)